These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 7917002)
41. Ethanol-induced suppression of LTP can be attenuated with an angiotensin IV analog. Wright JW; Kramár EA; Myers ED; Davis CJ; Harding JW Regul Pept; 2003 May; 113(1-3):49-56. PubMed ID: 12686460 [TBL] [Abstract][Full Text] [Related]
42. Monosialoanglioside (GM1) prevents lead-induced neurotoxicity on long-term potentiation, SOD activity, MDA levels, and intracellular calcium levels of hippocampus in rats. She JQ; Wang M; Zhu DM; Tang M; Chen JT; Wang L; Ruan DY Naunyn Schmiedebergs Arch Pharmacol; 2009 May; 379(5):517-24. PubMed ID: 19043692 [TBL] [Abstract][Full Text] [Related]
43. Monosialoganglioside GM1 in cerebral ischemia. Carolei A; Fieschi C; Bruno R; Toffano G Cerebrovasc Brain Metab Rev; 1991; 3(2):134-57. PubMed ID: 1854596 [TBL] [Abstract][Full Text] [Related]
44. Evidence for the functional role of monosialoganglioside GM1 in synaptic transmission in the rat hippocampus. Wieraszko A; Seifert W Brain Res; 1986 Apr; 371(2):305-13. PubMed ID: 3008944 [TBL] [Abstract][Full Text] [Related]
45. Corticosterone effects on long-term potentiation in mouse hippocampal slices. Rey M; Carlier E; Talmi M; Soumireu-Mourat B Neuroendocrinology; 1994 Jul; 60(1):36-41. PubMed ID: 8090280 [TBL] [Abstract][Full Text] [Related]
46. Econazole, a blocker of Ca2+ influx, selectively suppresses LTP of EPSPs in hippocampal slices. Forghani R; Krnjević K Neurosci Lett; 1995 Aug; 196(1-2):122-4. PubMed ID: 7501238 [TBL] [Abstract][Full Text] [Related]
47. Tetanus during a high extracellular calcium pulse overrides the block of long-term potentiation seen at 20 degrees C in the hamster hippocampal slice. Krelstein MS; Horowitz JM Brain Res; 1990 Dec; 536(1-2):105-13. PubMed ID: 1982235 [TBL] [Abstract][Full Text] [Related]
48. Experiential factors in the expression of hypermotility produced by intradentate colchicine: lack of effect of GM1 ganglioside on colchicine-induced loss of granule cells and mossy fibers. Tilson HA; Harry GJ; Nanry K; Rogers B; Peterson J; Jensen K; Dyer R J Neurosci Res; 1987; 17(4):410-6. PubMed ID: 3625805 [TBL] [Abstract][Full Text] [Related]
49. Acute effects of antidepressant drugs on long-term potentiation (LTP) in rat hippocampal slices. Birnstiel S; Haas HL Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):79-83. PubMed ID: 1837845 [TBL] [Abstract][Full Text] [Related]
50. Ganglioside GM1 prevents N-methyl-D-aspartate neurotoxicity in rabbit hippocampus in vivo. Effects on calcium homeostasis. Lazarewicz JW; Salińska E; Matyja E Mol Chem Neuropathol; 1995; 24(2-3):165-77. PubMed ID: 7632320 [TBL] [Abstract][Full Text] [Related]
52. Long-term potentiation in the in vitro perirhinal cortex displays associative properties. Bilkey DK Brain Res; 1996 Sep; 733(2):297-300. PubMed ID: 8891314 [TBL] [Abstract][Full Text] [Related]
53. Monosialoganglioside GM1 shortens the blood circulation time of liposomes in rats. Liu D; Liu F; Song YK Pharm Res; 1995 Apr; 12(4):508-12. PubMed ID: 7596984 [TBL] [Abstract][Full Text] [Related]
54. In vivo treatment with GM1 prevents the rapid decay of ATPase activities and mitochondrial damage in hippocampal slices. Bianchi R; Janigro D; Milan F; Giudici G; Gorio A Brain Res; 1986 Feb; 364(2):400-4. PubMed ID: 2936428 [TBL] [Abstract][Full Text] [Related]
55. The taurine transporter substrate guanidinoethyl sulfonate mimics the action of taurine on long-term synaptic potentiation. Suárez LM; Muñoz MD; González JC; Bustamante J; Del Río RM; Solís JM Amino Acids; 2016 Nov; 48(11):2647-2656. PubMed ID: 27422547 [TBL] [Abstract][Full Text] [Related]
56. Monosialoganglioside GM1 reduces NMDA neurotoxicity in neonatal rat brain. Lipartiti M; Lazzaro A; Zanoni R; Mazzari S; Toffano G; Leon A Exp Neurol; 1991 Sep; 113(3):301-5. PubMed ID: 1915720 [TBL] [Abstract][Full Text] [Related]
57. Hypoxic-ischemic damage and the neuroprotective effects of GM1 ganglioside. Leon A; Lipartiti M; Seren MS; Lazzaro A; Mazzari S; Koga T; Toffano G; Skaper SD Stroke; 1990 Nov; 21(11 Suppl):III95-7. PubMed ID: 2237992 [TBL] [Abstract][Full Text] [Related]
58. The monosialoganglioside GM1 dose-dependently reduces regional cerebral metabolic rates for glucose in awake rats. Freo U; Dam M; Pizzolato G; Pietrini P; Soncrant TT; Battistin L Brain Res; 1993 Sep; 621(1):175-9. PubMed ID: 8106115 [TBL] [Abstract][Full Text] [Related]
59. The multi-tasked life of GM1 ganglioside, a true factotum of nature. Ledeen RW; Wu G Trends Biochem Sci; 2015 Jul; 40(7):407-18. PubMed ID: 26024958 [TBL] [Abstract][Full Text] [Related]
60. Destruction of specific hippocampal cell fields increases ornithine decarboxylase activity: modulation of the biochemical but not the histological changes by ganglioside GM1. Walsh TJ; Emerich DF; Bondy SC Exp Neurol; 1989 Jul; 105(1):54-61. PubMed ID: 2744127 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]